October 2012, 11:119,
Open Access This content is freely available online to anyone, anywhere at any time.
Date: 03 Oct 2012
Plasma NT-proBNP and white matter hyperintensities in type 2 diabetic patients
Elevated plasma N-terminal (NT)-proBNP from the heart as well as white matter hyperintensities (WMH) in the brain predict cardiovascular (CV) mortality in the general population. The cause of poor prognosis associated with elevated P-NT-proBNP is not known but WMH precede strokes in high risk populations. We assessed the association between P-NT-proBNP and WMH or brain atrophy measured with magnetic resonance imaging (MRI) in type 2 diabetic patients, and age-matched controls.
Methods and results
We measured P-NT-proBNP(ng/l) in 20 diabetic patients without prior stroke but with(n = 10) or without(n = 10) asymptomatic coronary artery disease(CAD) in order to include patients with a wide-ranging CV risk profile. All patients and 26 controls had a 3D MRI and brain volumes(ml) with WMH and brain parenchymal fraction(BPF), an indicator of brain atrophy, were determined.
P-NT-proBNP was associated with WMH in linear regression analysis adjusted for CV risk factors(r = 0.94, p = 0.001) and with BPF in univariate analysis(r = 0.57, p = 0.009). Patients divided into groups of increased P-NT-proBNP levels were paralleled with increased WMH volumes(geometric mean[SD];(2.86[5.11] ml and 0.76[2.49] ml compared to patients with low P-NT-proBNP 0.20[2.28] ml, p = 0.003)) and also when adjusted for age, sex and presence of CAD(p = 0.017). The association was strengthened by CV risk factors and we did not find a common heart or brain specific driver of both P-NT-proBNP and WMH. Patients and particular patients with CAD had higher WMH, however no longer after adjustment for age and sex.
P-NT-proBNP was associated with WMH in type 2 diabetic patients, suggesting a linkage between heart and brain disease.
Debette S, Markus HS: The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. Br Med J 2010, 341:c3666.CrossRef
Reinhard H, Wiinberg N, Hansen PR, et al.: NT-proBNP levels, atherosclerosis and vascular function in asymptomatic type 2 diabetic patients with microalbuminuria: peripheral reactive hyperaemia index but not NT-proBNP is an independent predictor of coronary atherosclerosis. Cardiovasc Diabetol 2011, 10:71.PubMedCrossRef
Tombaugh TN, McIntyre NJ: The mini-mental state examination: a comprehensive review. J Am Geriatr Soc 1992,40(9):922-935.PubMed
Schultz HD, Gardner DG, Deschepper CF, et al.: Vagal C-fiber blockade abolishes sympathetic inhibition by atrial natriuretic factor. Am J Physiol 1988,255(1 Pt 2):R6-R13.PubMed
Jiang C, Lu H, Vincent KA, et al.: Gene expression profiles in human cardiac cells subjected to hypoxia or expressing a hybrid form of HIF-1 alpha. Physiol Genomics 2002,8(1):23-32.PubMed
Peng XL, Lin ZP, Zhang RK, et al.: [B-type natriuretic peptides and subclinical target organ damage in essential hypertensive patients]. Nan Fang Yi Ke Da Xue Xue Bao 2010,30(10):2347-2350.PubMed
Abdullah SM, Khera A, Das SR, et al.: Relation of coronary atherosclerosis determined by electron beam computed tomography and plasma levels of n-terminal pro-brain natriuretic peptide in a multiethnic population-based sample (the Dallas Heart Study). Am J Cardiol 2005,96(9):1284-1289.PubMedCrossRef
Christensen LL, Anker-Nielsen A, Almdal TP: Development in Quality of Treatment in Complicated Type 2 Diabetes Assessed by the Proportion of Patients Reaching ADA Goals. Diab 2010, 59:A180-A181.
Saritas A, Cakir Z, Emet M, et al.: Factors affecting the B-type natriuretic peptide levels in stroke patients. Ann Acad Med Singapore 2010,39(5):385-389.PubMed
van HB, de Leeuw FE, Weinstein HC, et al.: Brain imaging in patients with diabetes: a systematic review. Diabetes Care 2006,29(11):2539-2548.CrossRef
De BJ, Tiehuis AM, van den Berg E, et al.: Progression of cerebral atrophy and white matter hyperintensities in patients with type 2 diabetes. Diabetes Care 2010,33(6):1309-1314.CrossRef
- Plasma NT-proBNP and white matter hyperintensities in type 2 diabetic patients
- Open Access
- Available under Open Access This content is freely available online to anyone, anywhere at any time.
- Online Date
- October 2012
- Online ISSN
- BioMed Central
- Additional Links
- Type 2 diabetes
- Plasma NT-proBNP
- 3-D magnetic resonance imaging
- White matter hyperintensities
- Brain parenchymal fraction
- Author Affiliations
- 1. Steno Diabetes Center, Gentofte, Denmark
- 2. Danish Research Centre for Magnetic Resonance, Copenhagen University Hospital, Hvidovre, Denmark
- 7. Decision Neuroscience Research Group, Dept. of Marketing, Copenhagen Business School, Frederiksberg, Denmark
- 3. Department of Clinical Biochemistry, Frederiksberg University Hospital, Frederiksberg, Denmark
- 4. Department of Medical Endocrinology, University Hospital of Copenhagen, Copenhagen, Denmark
- 5. Faculty of Health Science, Aarhus University, Aarhus, Denmark
- 6. The Heart Centre, Rigshospitalet & University of Copenhagen, Copenhagen, Denmark